Gema Grahasarana Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Gema Grahasarana Tbk. trades at Rp80 (market cap 129.6B, 205.4K 24h volume), while Prodia Diagnostic Line Tbk trades at Rp264 (market cap 470.58B, 14.59M 24h volume). The key difference: Prodia Diagnostic Line Tbk is far larger — about 3.6× Gema Grahasarana Tbk.'s market cap, and Prodia Diagnostic Line Tbk is more actively traded (14.59M versus 205.4K). Which is the better fit depends on your goals.
| GEMA | PRDL | |
|---|---|---|
Market Cap | 129.6B | 470.58B |
Volume | 205.4K | 14.59M |
Lot | 2.05K | 145.93K |
Turnover | 16.57M | 3.84B |
Average Price | 80.66 | 263.18 |
Value | 16.57M | 3.84B |
Indicative Equilibrium Price | — | 272 |
Indicative Equilibrium Volume | — | 418 |
Trailing returns across standard periods
Latest headlines on both assets
PT Gema Grahasarana Tbk formerly PT Gema Gerhana Sarana (The Company) was established on December 7th 1984 in Jakarta. The corporate is a member of Vinoti business. The core business is in manufacture, trade and services of interior & furniture. Corporate have 2 subsidiaries: 1. LKS which conduct in industry, trade & service of panel component of furniture & interior. 2. PGM which conduct in industry, trade & construction service of mechanical, electrical for industrial, commercial & industrial.
Read more on GEMA →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →